Biopsychosocial Determinants of Quality of Life in Patients with Hepatitis B and C: Quality of Life in Patients with Hepatitis B and C

Syed Messum Ali Kazmi; Rabia Iftikhar

doi:10.54393/pjhs.v4i10.1077

Authors

Syed Messum Ali Kazmi Department of Psychology, Government College University, Lahore, Pakistan
Rabia Iftikhar Department of Clinical Psychology, Government College University, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i10.1077

Keywords:

Quality of Life, Hepatitis B, Hepatitis C, Psychiatric Comorbidities

Abstract

Hepatitis B and C are highly contagious viral diseases that impact the liver. Past research findings have identified that in addition to the physical burden of disease, there are numerous psychopathological consequences of these diseases including depression, anxiety, stress and other psychiatric comorbidities. Objectives: To assess the prevalence of psychiatric comorbidities in patients, perceived immune status, social support, resilience, health and physical lifestyle and the predictive role of these factors in impacting quality of life in patients with Hepatitis B and C. Methods: a correlational research design was used with an independently drawn sample of 400 participants (196 with chronic HBV and 204 with chronic HCV) with the mean age of 40.8 years and a balanced gender distribution. The sample size was finalized using G power analysis with 95 % confidence intervals. Normality checks were also performed on the data through assessing skewness, kurtosis and shape of the distribution. Cross Cutting Symptoms Measure, Essential Resilience Scale, Immune Status Questionnaire, Health and Life Style Scale and WHO Qol BREF scale were used. Results: The findings showed that cross cutting symptoms (depression, anger, anxiety, somatic symptoms, suicidal ideation, psychosis, sleep problems, memory, repetitive thoughts and behaviors, dissociation, personality functioning, substance abuse) had a significant negative predictive association with health and lifestyle, perceived immune status, resilience. Conclusions: It has been assessed that cross cutting symptoms, perceived immune status, health and lifestyle factors, social support and resilience significantly impact quality of life.

References

Brakenhoff SM, de Man RA, de Knegt RJ, Bindels PJ, de Schepper EI. Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database. Family Practice. 2023 Feb; 40(1): 83-90. doi: 10.1093/fampra/cmac070. DOI: https://doi.org/10.1093/fampra/cmac070

Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World Journal of Gastroenterology. 2019 Jul; 25(27): 3527. doi: 10.3748/wjg.v25.i27.3527. DOI: https://doi.org/10.3748/wjg.v25.i27.3527

World Health Organization. Guidelines for the screening care and treatment of persons with chronic hepatitis C infection. 2016. [Last cited: 20th Oct 2020]. Available at: https://www.who.int/publications/i/item/9789241550345.

Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, et al. Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023. MMWR Recommendations and Reports. 2023 Mar; 72(1): 1. doi: 10.15585/mmwr.rr7201a1. DOI: https://doi.org/10.15585/mmwr.rr7201a1

Lluch E and Miller BJ. Rates of hepatitis B and C in patients with schizophrenia: A meta-analysis. General Hospital Psychiatry. 2019 Nov; 61: 41-6. doi: 10.1016/j.genhosppsych.2019.10.007. DOI: https://doi.org/10.1016/j.genhosppsych.2019.10.007

Fındıklı E, Ateş S, Kandemir B, Karaaslan MF, Camkurt MA, İzci F, et al. A case-control study on the temperament and Psychological mood of patients with chronic Hepatitis B. European Journal of General Medicine. 2017 Aug; 14(3): 58-62. doi: 0.29333/ejgm/81887. DOI: https://doi.org/10.29333/ejgm/81887

Daida YG, Boscarino JA, Moorman AC, Lu M, Rupp LB, Gordon SC, et al. Mental and physical health status among chronic hepatitis B patients. Quality of Life Research. 2020 Jun; 29: 1567-77. doi: 10.1007/s11136-020-02416-6. DOI: https://doi.org/10.1007/s11136-020-02416-6

Choi HG, Soh JS, Lim JS, Sim SY, Lee SW. Association between dementia and hepatitis B and C virus infection. Medicine. 2021 Jul; 100(29): e26476. doi: 10.1097/MD.0000000000026476. DOI: https://doi.org/10.1097/MD.0000000000026476

Meng Z, Chen Y, Lu M. Advances in targeting the innate and adaptive immune systems to cure chronic hepatitis B virus infection. Frontiers in Immunology. 2020 Feb; 10: 3127. doi: 10.3389/fimmu.2019.03127. DOI: https://doi.org/10.3389/fimmu.2019.03127

Kang H. Sample size determination and power analysis using the G* Power software. Journal of educational evaluation for health professions. 2021 Jul; 18: 17. doi: 10.3352/jeehp.2021.18.17. DOI: https://doi.org/10.3352/jeehp.2021.18.17

Butterworth RF. Hepatic encephalopathy in cirrhosis: pathology and pathophysiology. Drugs. 2019 Feb; 79(Suppl 1): 17-21. doi: 10.1007/s40265-018-1017-0. DOI: https://doi.org/10.1007/s40265-018-1017-0

Wilod Versprille LJ, van de Loo AJ, Mackus M, Arnoldy L, Sulzer TA, Vermeulen SA, et al. Development and validation of the Immune Status Questionnaire (ISQ). International Journal of Environmental Research and Public Health. 2019 Dec; 16(23): 4743. doi: 10.3390/ijerph16234743. DOI: https://doi.org/10.3390/ijerph16234743

Chen X, Wang Y, Yan Y. The essential resilience scale: instrument development and prediction of perceived health and behaviour. Stress and Health. 2016 Dec; 32(5): 533-42. doi: 10.1002/smi.2659. DOI: https://doi.org/10.1002/smi.2659

Narrow WE, Clarke DE, Kuramoto SJ, Kraemer HC, Kupfer DJ, Greiner L, et al. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. American Journal of Psychiatry. 2013 Jan; 170(1): 71-82. doi: 10.1176/appi.ajp.2012.12071000. DOI: https://doi.org/10.1176/appi.ajp.2012.12071000

Whoqol Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine. 1998 May; 28(3): 551-8. doi: 10.1017/S0033291798006667. DOI: https://doi.org/10.1017/S0033291798006667

Lodhi FS, Raza O, Montazeri A, Nedjat S, Yaseri M, Holakouie-Naieni K. Psychometric properties of the Urdu version of the World Health Organization's quality of life questionnaire (WHOQOL-BREF). Medical Journal of the Islamic Republic of Iran. 2017; 31: 129. doi: 10.14196/mjiri.31.129. DOI: https://doi.org/10.14196/mjiri.31.129

Tartaglia S. Different predictors of quality of life in urban environment. Social Indicators Research. 2013 Sep; 113: 1045-53. doi: 10.1007/s11205-012-0126-5. DOI: https://doi.org/10.1007/s11205-012-0126-5

Pokorska‐Śpiewak M, Talarek E, Aniszewska M, Pluta M, Dobrzeniecka A, Marczyńska M, et al. Health‐related quality of life in patients aged 6–18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir. Liver International. 2023 Sep; 00: 1-10. doi:10.1111/liv.15744 DOI: https://doi.org/10.1111/liv.15744

Sertoz OO, Tuncel OK, Tasbakan MI, Pullukcu H, Onmus IR, Yamazhan T, et al. Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis B. Psychiatry and Clinical Psychopharmacology. 2017 Jan; 27(1): 47-53. doi: 10.1080/24750573.2017.1293251. DOI: https://doi.org/10.1080/24750573.2017.1293251

Younossi ZM, Stepanova M, Younossi I, Papatheodoridis G, Janssen HL, Agarwal K, et al. Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication. Liver International. 2019 Oct; 39(10): 1837-44. doi: 10.1111/liv.14171. DOI: https://doi.org/10.1111/liv.14171

Zhu HP, Gu YR, Zhang GL, Su YJ, Wang KE, Zheng YB, et al. Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis. Experimental and Therapeutic Medicine. 2016 Jul; 12(1): 405-9. doi: 10.3892/etm.2016.3271. DOI: https://doi.org/10.3892/etm.2016.3271

Oh CH and Lee JS. Innumerable cerebral microbleeds in hepatitis B virus-related decompensated liver cirrhosis: a case report. BMC Neurology. 2021 Dec; 21: 1-4. doi: 10.1186/s12883-021-02291-9. DOI: https://doi.org/10.1186/s12883-021-02291-9

Yousef MH, Al Juboori A, Albarrak AA, Ibdah JA, Tahan V. Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients. World Journal of Gastrointestinal Pathophysiology. 2017 Aug; 8(3): 100. doi: 10.4291/wjgp.v8.i3.100. DOI: https://doi.org/10.4291/wjgp.v8.i3.100

Lieber SR, Baldelli L, Kim HP, Nash RP, Ramirez AN, Magee G, et al. Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors. Liver Transplantation. 2023 Mar; 29(3): 290-306. doi: 10.1097/LVT.0000000000000009. DOI: https://doi.org/10.1097/LVT.0000000000000009

Gormley MA, Akiyama MJ, Rennert L, Howard KA, Norton BL, Pericot-Valverde I, et al. Changes in health-related quality of life for hepatitis C virus–infected people who inject drugs while on opioid agonist treatment following sustained virologic response. Clinical Infectious Diseases. 2022 May; 74(9): 1586-93. doi: 10.1093/cid/ciab669. DOI: https://doi.org/10.1093/cid/ciab669

Mace RA, Doorley J, Bakhshaie J, Cohen JE, Vranceanu AM. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis. Journal of Neuro-Oncology. 2021 Nov; 155: 125-32. doi: 10.1007/s11060-021-03852-1. DOI: https://doi.org/10.1007/s11060-021-03852-1